---
title: "SMMT: Ivonescimab advances in Phase III, but funding shortfall raises going concern risk"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293661623.md"
description: "Lead oncology asset ivonescimab showed strong PFS results in Phase III trials, but FDA approval hinges on OS significance. Net loss narrowed year-over-year, but liquidity is insufficient for the next 12 months, raising going concern risk.Original document: Summit Therapeutics Inc. [SMMT] SEC 10-Q Quarterly Report — Jul. 23 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-23T20:13:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293661623.md)
  - [en](https://longbridge.com/en/news/293661623.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293661623.md)
generator: "portal-rs"
---

# SMMT: Ivonescimab advances in Phase III, but funding shortfall raises going concern risk

Lead oncology asset ivonescimab showed strong PFS results in Phase III trials, but FDA approval hinges on OS significance. Net loss narrowed year-over-year, but liquidity is insufficient for the next 12 months, raising going concern risk.

Original document: Summit Therapeutics Inc. \[SMMT\] SEC 10-Q Quarterly Report — Jul. 23 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [SMMT.US](https://longbridge.com/en/quote/SMMT.US.md)

## Related News & Research

- [Ivonescimab regimen shows OS superiority in Phase III HARMONi-GI1, Summit Therapeutics notes](https://longbridge.com/en/news/297053863.md)
- [Summit says FDA sets Nov. 14, 2026 action date for ivonescimab lung cancer filing](https://longbridge.com/en/news/296901535.md)
- [Meta Stock Outlook: Named Top Pick by Morgan Stanley, Will the Stock Recover?](https://longbridge.com/en/news/296659391.md)
- [Report outlines AI’s workplace effects](https://longbridge.com/en/news/296637254.md)
- [15:10 ETProsci Announces Infinite Change Executive Summit to Help Leaders Navigate AI and Continuous Transformation](https://longbridge.com/en/news/296948828.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**